Beta thalassemia
Tracked across 1 events · 8 articles · First seen Jun 02, 2026 · Last active Jun 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: CorrectSequence Therapeutics has also developed CS-101 for Beta thalassemia, with successful clinical trials demonstrating its effectiveness, further solidifying the company's position in treating hemoglobinopathies.
Jun 02, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Beta thalassemia live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard